The Pharmacy Times® Breast Cancer Resource Center is a comprehensive resource for clinical news and expert insights on issues related to cancers that occur in the breast, including invasive ductal carcinoma, invasive lobular carcinoma, and less common forms of the disease.
December 5th 2024
The authors suggest that targeted interventions to mitigate financial toxicity should be implemented to better support patients.
Impact of the COVID-19 Pandemic on Breast Cancer Treatment, Management Across the Country
December 9th 2020There were significant modifications in breast cancer treatment due to the coronavirus disease 2019 pandemic, such as high rates of NET chemotherapy, genomic assay testing on core biopsies, and delays in planned surgeries.
Read More
Capecitabine Versus Endocrine Therapy as a Maintenance Therapy for Metastatic Breast Cancer
December 9th 2020ET and CT are used as standard maintenance therapy for HR-positive and HER-negative MBC in clinical practice, and there was no prospective study data on which is better, according to the study authors.
Read More
New Optical Method Could Enable Cancer Biomarker Breath Test
December 1st 2020The new optical sensing method is based on multi-pass spectroscopy and can detect the presence of 1 molecule of formaldehyde in a million air particles, or 1 part per million, even in the presence of gasses that often interfere with optical measurements.
Read More
Study: Black Women More Likely to Experience Delays in Breast Cancer Treatment
November 5th 2020Black women experience longer waiting periods before treatment is initiated than White women following a breast cancer diagnosis, as well as a prolonged treatment duration compared with White women.
Read More
FDA Approves FoundationOne Liquid CDx for Breast, Ovarian, Lung Cancer Indications
October 28th 2020FDA approves FoundationOne Liquid CDx as a companion diagnostic for alpelisib in advanced or metastatic breast cancer, rucaparib in advanced ovarian cancer, and alectinib in a specific type of metastatic non–small cell lung cancer.
Read More
Axillary Surgery May Not Be Required for All Women With Invasive Breast Cancer
October 27th 2020An axillary lymph node dissection, which is the surgical removal of 10 to 20 lymph nodes from the breast, is a procedure conducted in up to 25% of women with breast cancer to disable symptoms of arm swelling.
Read More
Combination Therapy Shows Promise in Breast Cancer Patients With Advanced Solid Tumors
September 23rd 2020Lenvatinib (Lenvima) plus pembrolizumab (Keytruda) showed early antitumor activity and tolerability in previously treated triple-negative breast cancer patients with advanced solid tumors.
Read More
Trial Finds Breast Cancer Drug Set to Transform Prostate Cancer Treatment
September 22nd 2020Trial shows that olaparib, a poly ADP ribose polymerase inhibitor that is the first cancer drug to target an inherited genetic fault, can be used successfully to treat prostate cancers with a weakness in the ability to repair damaged DNA.
Read More